 |
Articles: General Pharma |
Prior Articles
Repligen Announces Completion of Patient Treatment in Phase 3 Clinical Trial of RG1068 in MRI Imaging of the Pancreas
Repligen, 10/20/09
Free full text
Shire voluntarily enables further access to HIV/AIDS medicines for Rwanda
Shire, 10/20/09 Leading Dengue and TB scientists discuss new clinical research approaches and models of excellence for clinical research and trials in endemic regions
Novartis, 10/20/09
Free full text
XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09 100-Year-Old Woman Gets Relief from Debilitating Back Pain after Minimally Invasive Spine Surgery
Medtronic, 10/20/09
Free full text
Boston Scientific Announces Results for Third Quarter Ended September, 2009
Boston Scientific, 10/20/09
Free full text
The Joint Commission unveils its Center for Transforming Healthcare
Health Facilities Management, 10/20/09
Free full text
Let your learning continue
Health Facilities Management, 10/20/09
Free full text
Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09
Free full text
Emerging Pharma Leadership Awards - Michelle Dipp
PharmExec, 10/20/09 Emerging Leaderhip Pharma Awards- Frank Karbe
PharmExec, 10/20/09 ERGONEX Pharma receives Frost & Sullivan's European Orphan Diseases Entrepreneurial Company Award 2009
b3c newswire, 10/20/09 FDA Approves GARDASIL for Use in Boys and Young Men
Merck & Co., 10/19/09
Free full text
Dexlansoprazole MR
Expert Opinion in Pharmacotherapy, 10/19/09 Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin Application for Approval of Additional Indication of Breast Cancer
Chugai Pharmaceutical Co., 10/19/09
Free full text
FDA approves Cervarix, GlaxoSmithKlines cervical cancer vaccine
GlaxoSmithKline, 10/19/09
Free full text
ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone
Roche, 10/19/09
Free full text
U.S. Food and Drug Administration approves CRESTOR for use in pediatric patients with heterozygous familial hypercholesterolemia
AstraZeneca, 10/19/09
Free full text
Pandemic 2009 Influenza Update: Results from second clinical trial of GSKs H1N1 adjuvanted vaccine confirm immune response and tolerability
GlaxoSmithKline, 10/19/09
Free full text
Phase III Study Showed Two Years of ACTEMRA Inhibited Progression of Joint Damage and Improved Disease Remission
Genentech, 10/19/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
